Rayyan

Systematic-review screening with blind mode, dedup and AI assistance

Research & Data Freemium
Researched · Published · Reviewed
RECATOOLS Score
7.2 / 10
Capability
7
Value for money
8
Ease of use
7
ASEAN readiness
6
API quality
3
Founded
2014
HQ
Doha, Qatar
Users
300k+ researchers
Launched
2016
Developer
Mourad Ouzzani, Hossam Hammady

Overview

Rayyan is a web and mobile platform for screening references in systematic and scoping reviews, with blind dual screening, duplicate detection, relevance ranking, risk-of-bias assessment and, on institutional plans, the ResearchPilot AI reviewer and extraction tools. It began at the Qatar Computing Research Institute and is run by Rayyan Systems, Inc. of Cambridge, Massachusetts. A free plan covers three active reviews.

Advertisement

Pricing

Pricing shown for reference only. These figures reflect RECATOOLS research as of 14 Oct 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.

Free
$0
Free forever
  • 3 active reviews
  • 2 invited reviewers and 1 sample
  • Duplicate detection and AI relevance predictions
  • Limited mobile app access
Essential
$4.99/seat/month
Billed annually; $8.33/month billed quarterly
  • PRISMA flow diagrams
  • 5 invited reviewers
  • Auto-resolve duplicates
  • Unlimited mobile app access
Business/Academic
$41.67/licence/month
Billed annually, from 5 licences ($2,500); academic discounts
  • ResearchPilot AI
  • 250 invited reviewers
  • 50 org-wide reviews
  • Team dashboard and workspace roles
Enterprise
Quoted on request
Billed annually
  • Unlimited reviews and viewers
  • SSO/SAML
  • Rayyan API
  • Management console and dedicated support

Use cases

Screening 5,000 abstracts for a systematic review of diabetes interventions Conducting blinded dual-reviewer screening while sharing the same digital platform Prioritising the most likely relevant papers for initial reading based on AI recommendations

What you can produce with Rayyan

  • Blind dual screening of titles and abstracts, with conflicts surfaced when the blind is lifted
  • A screening queue reordered by AI relevance predictions as you label
  • Duplicate records detected on import, and auto-resolved on paid plans
  • A PRISMA 2020 flow diagram generated from your screening decisions
  • Structured risk-of-bias assessments using RoB 2, ROBINS-I, QUADAS-2 or a custom framework
  • AI Reviewer screening decisions and automatic data extraction with ResearchPilot (institutional plans)
Advertisement
RECATOOLS Verdict

Rayyan is still the default screening tool for systematic reviews: blind dual screening, reliable duplicate handling and relevance ranking work well, and the free plan is enough for a first review. Individual plans are cheap if you pay yearly, but there is no monthly billing.

The newer ResearchPilot AI is reserved for Business/Academic and Enterprise plans, and Rayyan publishes no accuracy figures for it, so use it as an extra screener whose calls you check. Good value for evidence-synthesis teams, including university departments in ASEAN; irrelevant outside that workflow.

Desk research by RECATOOLS from public sources, written with AI assistance — not a hands-on test. How we review

What we found

Rayyan is a web and mobile app for the screening stage of systematic and scoping reviews: importing search results, removing duplicates, and deciding with colleagues which studies make it in. It began at the Qatar Computing Research Institute, whose researchers first presented it at a Cochrane technology symposium in 2014 and described it in the journal Systematic Reviews in 2016. Today it is run by Rayyan Systems, Inc. of Cambridge, Massachusetts, whose terms refer to software licensed from Qatar Foundation. It claims more than a million researchers at over 30,000 institutions.

The core workflow is well proven. Blind mode hides each reviewer's calls from the others until the blind is lifted, relevance predictions reorder the queue as you label, PICO terms are highlighted, and duplicates are detected on import. A newer risk-of-bias workspace supports frameworks such as RoB 2, ROBINS-I and QUADAS-2. The AI that gets the attention is ResearchPilot: an AI Reviewer that screens against your criteria as a member of the team, an AI Analyzer that suggests decisions with reasons, chat over your dataset and automatic data extraction. Rayyan publishes no accuracy figures for any of these, only a claim that users save up to 90% of their time, so treat an AI decision as a second screener to check rather than one to cite.

Pricing has changed again. The free plan allows three active reviews, two invited reviewers and limited mobile use. Essential costs $4.99 a seat a month billed annually, or $8.33 billed quarterly, and adds PRISMA diagrams and automatic duplicate resolution. Advanced is $8.33 annually or $13.33 quarterly, with nine active reviews and AI-assisted PICO extraction. There is no monthly billing, and the Professional and Student plans this page used to list are gone. ResearchPilot starts at Business/Academic, $41.67 per licence a month billed annually with a five-licence minimum; the API sits on the quoted Enterprise plan.

For evidence-synthesis teams it remains a sensible default; outside that workflow it is the wrong tool.

Compiled by RECATOOLS from public sources: vendor documentation and pricing, code repositories and published reporting.

Notable facts

  • Rayyan has processed over 50 million abstract screenings, making it one of the most heavily used academic research tools in existence.
  • The platform was developed at the Qatar Computing Research Institute, making it one of the first major AI research tools to emerge from the Middle East.
  • Rayyan's AI can reduce abstract screening time by up to 80%, potentially compressing a 6-month systematic review into 6 weeks.

Frequently asked questions

Yes. Individual researchers can run unlimited systematic reviews for free.
No. It assists human reviewers by prioritising likely relevant abstracts and learning from decisions.
RIS, NBIB, CSV, and direct import from PubMed and other databases.
Yes. Blind mode allows multiple independent reviewers.
Yes. Rayyan is widely used for Cochrane and similar evidence-based medicine reviews.

About this listing

Researched on
Published on
Last reviewed

This entry was compiled from publicly available data including Rayyan's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Rayyan unless explicitly stated.

Data accuracy

Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.

For the latest details, please refer to Rayyan directly →

Spotted something out of date? Suggest an update →

Advertisement